N-Nitroso Edoxaban Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Edoxaban is used to prevent stroke and blood clots in patients with a certain heart rhythm problem (eg, nonvalvular atrial fibrillation). Edoxaban is also used to treat deep venous thrombosis, a condition in which harmful blood clots form in the blood vessels of the legs.N-Nitroso Edoxaban Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Edoxaban Impurity 1 chemically represented as 5-nitroso-4,5,6,7- tetrahydrothiazolo[5,4-c] pyridin-2-amine.Synchemia is the leading manufacturing and exporter of N-Nitroso Edoxaban Impurity 1 .We supply N-Nitroso Edoxaban Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141015 |
| CAS No | NA |
| Mol.F. | C16H24ClN5O6S |
| Mol.Wt. | 449.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141016 |
| CAS No | NA |
| Mol.F. | C19H28ClN5O6S |
| Mol.Wt. | 490.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141017 |
| CAS No | NA |
| Mol.F. | C23H27F2N7O5S |
| Mol.Wt. | 551.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141018 |
| CAS No | NA |
| Mol.F. | C17H26ClN5O5S |
| Mol.Wt. | 447.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141019 |
| CAS No | NA |
| Mol.F. | C23H27F2N7O5S |
| Mol.Wt. | 551.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141020 |
| CAS No | NA |
| Mol.F. | C23H27F2N7O5S |
| Mol.Wt. | 551.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141021 |
| CAS No | 2476859-55-7 |
| Mol.F. | C23H27F2N7O5S |
| Mol.Wt. | 551.6 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141022 |
| CAS No | NA |
| Mol.F. | C19H19N5O2 |
| Mol.Wt. | 349.4 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141023 |
| CAS No | NA |
| Mol.F. | C19H18N4O3 |
| Mol.Wt. | 350.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141024 |
| CAS No | NA |
| Mol.F. | C24H27N5O5 |
| Mol.Wt. | 465.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141025 |
| CAS No | NA |
| Mol.F. | C20H21ClN4O2 |
| Mol.Wt. | 384.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141026 |
| CAS No | NA |
| Mol.F. | C18H17ClN4O2 |
| Mol.Wt. | 356.8 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141027 |
| CAS No | NA |
| Mol.F. | C13H17Br2N3O2 : C9H10N4O4 |
| Mol.Wt. | 407.1 : 238.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141028 |
| CAS No | NA |
| Mol.F. | C10H13N9O3S |
| Mol.Wt. | 339.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141029 |
| CAS No | 73785-40-7 |
| Mol.F. | C10H15N7OS |
| Mol.Wt. | 281.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141030 |
| CAS No | NA |
| Mol.F. | C10H15N7OS |
| Mol.Wt. | 281.3 |
| INV STATUS | CUSTOM SYNTHESIS |